ctrl K

Price Alert

AN2 Therapeutics Inc. (ANTX)

NASDAQ: ANTX · Real-Time Price · USD

1.10

0.05 (4.27%)

At close: Aug 15, 2025, 3:59 PM

1.11

0.78%

After-hours: Aug 15, 2025, 07:15 PM EDT

AN2 Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.35M	15.65M	27.22M	12.1M
Short-Term Investments	62.27M	91.65M	68.84M	46.46M
Long-Term Investments	5.02M	27.19M	3.22M	3.49M
Other Long-Term Assets	804K	1.04M	667K	1.72M
Receivables	300K	1.4M	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.34M	n/a	2.56M	n/a
Total Current Assets	86.26M	110.51M	98.62M	60.11M
Property-Plant & Equipment	n/a	n/a	53K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.83M	28.24M	3.94M	5.21M
Total Assets	92.09M	138.74M	102.56M	65.32M
Account Payables	3.32M	2.68M	2.12M	1.06M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	53K	n/a
Other Current Liabilities	2.47M	4.69M	2.79M	330K
Total Current Liabilities	10.24M	14.04M	7.19M	3.4M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	2K	13K
Total Long-Term Liabilities	n/a	n/a	2K	109.33M
Total Liabilities	10.24M	14.04M	7.19M	112.73M
Total Debt	n/a	n/a	53K	n/a
Common Stock	n/a	n/a	n/a	n/a
Retained Earnings	-205.78M	-154.46M	-89.72M	-47.38M
Comprehensive Income	31K	275K	-374K	-27K
Shareholders Equity	81.85M	124.7M	95.37M	61.91M
Total Investments	67.29M	118.84M	72.06M	49.94M